United Biomedical, a Taiwan biopharmaceutical firm developing COVID-19 vaccines, on Thursday said it had initially planned on following international norm and entering phase 3 clinical trials before seeking government approval for its COVID-19 vaccine.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Authorities warn of aftershocks following Taitung magnitude 6.1 quake
12/24/2025 09:58 PM - Politics
Verdict in trial of former Taipei Mayor Ko Wen-je set for March 26
12/24/2025 09:54 PM - Cross-Strait
China reward notice for Taiwanese nationals a 'political maneuver': Taiwan
12/24/2025 09:14 PM - Society
Antibiotic injection recalled after glass fragments found in vials: TFDA
12/24/2025 08:35 PM - Business
Taiwan's industrial production grows for 21st straight month on AI demand
12/24/2025 08:31 PM